Buchanan's addition of Matthew Fedowitz, Shareholder in the firm's Intellectual Property section, was highlighted in Law360's article "Buchanan Ingersoll Scores Merchant & Gould Drug Patent Pro."

It also ran in The Washington Post and the IPWatchdog.